Y. Y. Sun and Y. Chen Pages 983 - 987 ( 5 )
Imaging of glucose metabolism has resulted in significant improvements in staging and follow-up in oncology. 18F-FDG PET has become a routine clinical test for most solid tumours. Several radionuclide-labeled derivatives of deoxyglucose that have shown that glucose metabolic imaging may be a useful tool for improving tumour staging, restaging, and monitoring of tumour response to therapy.
18F-FDG,positron emission tomography,SPECT,imaging,radiopharmaceutical,9mTc,188Re
, Department of Nuclear Medicine, Affiliated Hospital, Luzhou Medical College, St. Taiping, Luzhou, Sichuan, 646000 China.